Search This Blog

Tuesday, March 26, 2019

Antares granted orphan status for ectopic pregnancy treatment

The FDA granted Antares Pharma orphan status for methotrexate, the company’s treatment of ectopic pregnancy.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.